Skip to content

Neogen

US · NEOG #2579 by market cap Listed 1970
10.55 -0.30 -2.77%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 10.75 -0.92%
After-hours 10.40 -1.42%
13.988.7510.552026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on NEOG?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +42.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 5.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C-

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth C-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 1.9% Better than 34%
Net income CAGR (3Y) -7.1% Better than 30%
Free cash flow CAGR (3Y) -3.9% Better than 34%
Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 46.9% Better than 59%
Operating margin -2.5% Better than 19%
Net margin -0.9% Better than 24%
Return on equity -0.4% Better than 27%
Return on invested capital 1.5% Better than 32%
Momentum B+

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -11.7% Better than 46%
6-month return 18.5% Better than 81%
12-month return (ex latest month) 109.4% Better than 96%
Distance below 52-week high 26.0% Better than 49%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.8x Better than 80%
Debt to assets 23.7% Better than 50%
Interest coverage 0.8x Better than 28%
Free cash flow / net income 90.3% Better than 32%
Analyst View B-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 66.7% Better than 41%
Upside to average target 32.7% Better than 52%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -6.06%
1M -9.98%
3M -10.82%
6M +19.48%
YTD +50.93%
1Y +95.01%
3Y -35.20%
5Y -76.02%

Key statistics

Price & volume

Prev close
10.85
Open
10.76
Day range
10.42 - 10.94
Avg price
10.57
Volume
3.04M
Turnover
32.07M
Amplitude
4.79%
52-week range
5.60 - 14.26

Valuation

P/E
-263.75
P/E (TTM)
-40.58
P/B
1.10
EPS
-0.04
Net profit
-8.73M
Net assets
2.09B

Share structure

Market cap
2.30B
Float cap
2.29B
Shares out
218.31M
Float shares
217.25M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 57% of range
5.60 14.26

26.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-25.06M net over the window

Short interest

Shares short
12.71M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Neogen (NEOG)?

Neogen last traded at 10.55. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Neogen's market cap?

About 2.30B.

What is the P/E ratio of Neogen?

The trailing twelve-month P/E is -40.58. The Valuation tab shows it against the stock's own five-year range.

Does Neogen pay a dividend?

Neogen does not currently pay a regular dividend.

Is Neogen a buy according to analysts?

The consensus of 3 analysts is a Buy rating, with an average 12-month price target of 14.00, which implies 32.7% upside from the current price. This is not investment advice.

What is Neogen's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Neogen a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Neogen discussion 0 comments

Add a comment